Date: 2026-02-23 Quarter: Q1 FY26 (September–November 2025, reported December 17, 2025) Market cap: ~$108B | P/S TTM: ~2.6x | Revenue growth: +56.7% YoY | EPS growth: +167% YoY
Q1 FY26 was Micron's best quarter in its 47-year history on every metric simultaneously: revenue, gross margin, operating margin, FCF, EPS — all all-time highs. The $13.6B print beat guidance midpoint by $1.1B (+9.1%). Q2 FY26 guidance of $18.7B implies another 37% sequential surge, with 68% gross margin guiding 11pp above Q1's record. HBM is sold out through calendar 2026 under locked LTAs. The valuation — 2.6x trailing P/S, ~5.2x trailing P/E, ~14% FCF yield — is the market demanding proof this cycle doesn't reverse. Conviction 4/5: extraordinary execution and historic cheapness argue for 5, but secular-versus-cyclical resolution is Q3/Q4 FY26's job.
| Criterion | Threshold | Actual | Pass? |
|---|---|---|---|
| Revenue YoY growth | >30% (>40% preferred) | +56.7% | PASS |
| Gross margin | >60% preferred | 56.0% GAAP / 56.8% Non-GAAP (68% guided Q2) | BORDERLINE — improving |
| Revenue per quarter | >$50M | $13.6B | PASS |
| Data availability | 4+ quarters | 37 quarters in DB | PASS |
| Share dilution | <10% annual | ~1% annual | PASS |
| GAAP profitability trajectory | Improving | $0 → $5.2B net income, 0% → 38.4% NM in 6 quarters | PASS |
Gross margin is the only soft point. GAAP GM of 56% misses the 60% threshold on a trailing basis. Q2 FY26 guide implies 68% — well above threshold. Not a disqualifying failure given cyclical context and clear trajectory.
| Factor | Rating | Detail |
|---|---|---|
| Growth | Strong | +56.7% YoY Q1 FY26; DRAM +69% YoY. Three consecutive acceleration quarters. |
| Trajectory | Accelerating | +36.6% Q3 FY25 → +46.0% Q4 FY25 → +56.7% Q1 FY26 → Q2 guide implies ~79% YoY |
| Margins | Mid / Rapidly improving | GAAP GM 56% (ATH); Non-GAAP GM 56.8% (ATH); 68% guided Q2. OM 45% GAAP / 47% Non-GAAP (ATH). |
| Dominance | Strong | #2 DRAM globally (25.7% share). #2 HBM globally (21% share, overtaking Samsung 17%). HBM TAM now concentrated: SK Hynix 62%, Micron 21%, Samsung 17%. |
| Valuation | Cheap | 2.6x P/S TTM, ~5.2x trailing P/E, ~14% FCF yield. At Q2 guide annualized: ~1.5x P/S, ~2.8x P/E. Extraordinary cheapness if margins hold even partially. |
| Special | Present | HBM TAM pulled forward 2 years: $35B (2025) → $100B (2028). Supply sold out CY26 under LTAs. 50-67% of hyperscaler demand currently unmet. Technology lead: HBM3E 30% lower power than SK Hynix; HBM4 at 11+ Gbps (industry-leading). |
| Q2 FY23 | Q3 FY23 | Q4 FY23 | Q1 FY24 | Q2 FY24 | Q3 FY24 | Q4 FY24 | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cal period | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 |
| Revenue ($B) | 3.75 | 3.76 | 4.01 | 5.82 | 6.81 | 7.75 | 7.75 | 8.71 | 8.05 | 9.30 | 11.30 | 13.60 |
| YoY% | -53% | -57% | -40% | +18% | +82% | +82% | +93% | +84% | +18% | +20% | +46% | +57% |
| QoQ% | -10% | 0% | +7% | +45% | +17% | +14% | 0% | +12% | -8% | +16% | +22% | +21% |
| GAAP GM% | -33% | -15% | +12% | +22% | +28% | +33% | +35% | +39% | +39% | +39% | +47% | +56% |
| GAAP OM% | -62% | -44% | -18% | -6% | +4% | +12% | +12% | +25% | +25% | +26% | +34% | +45% |
| GAAP NM% | -63% | -45% | -18% | -7% | +5% | +13% | +13% | +25% | +25% | +26% | +35% | +38% |
| GAAP EPS ($) | -1.73 | -1.43 | -0.41 | 0.45 | 0.62 | 1.18 | 1.18 | 1.79 | 1.56 | 1.91 | 3.05 | 4.48 |
| Non-GAAP EPS ($) | — | — | — | — | — | — | — | — | — | — | — | 4.78 |
| FCF ($B) | — | — | — | — | — | — | — | 1.3 | 0.9 | 1.9 | 3.0 | 3.9 |
Note: Historical quarters Q2 FY23–Q4 FY24 use EDGAR-sourced data from DB. Non-GAAP EPS prior quarters not reconstructed in DB. FCF Q1-Q3 FY25 estimated from operating CF minus CapEx.
Q2 FY26 Guide: Revenue 18.7B±400M (+37% QoQ, ~79% YoY) | GAAP GM ~67-68% | Non-GAAP EPS 8.42±0.20
Entering Q1 FY26 from my Q3 FY25 analysis, expecting continuation of HBM ramp with guided beat.
| Metric | Expected (Prior) | Actual | Verdict |
|---|---|---|---|
| Revenue | $12.5–13.0B (guided $12.5B ± $300M, expected modest beat) | 13.6B(+1.1B above guide midpoint) | Beat — guided beat magnitude again exceeded |
| GAAP Gross Margin | ~50–52% (extrapolating from $47% Q4 FY25) | 56.0% GAAP / 56.8% Non-GAAP | Significant upside surprise — pricing power beyond model |
| GAAP EPS | ~$3.50–4.00 | $4.48 GAAP / $4.78 Non-GAAP | Beat — margin flow-through underestimated |
| FCF | ~$2.5–3.0B | $3.9B (quarterly record, +386% QoQ) | Beat — cash conversion exceptional |
| HBM status | Sold out CY25, partial CY26 sold | 100% CY26 sold out under LTA; "50–67% of demand" unmet | Stronger than expected — LTA coverage confirmed |
| Forward guidance | $15–16B Q2 | $18.7B — blew past expectation | Massive upside; implies HBM volume ramp steeper than modeled |
| Gross margin trajectory | ~58–60% Q2 | 68% Non-GAAP guided | Extraordinary — 12pp sequential GM expansion guided |
Delta: Every single line beat. The guidance beat surprise is the most important number — 18.7BQ2guidewas 3B above the sell-side consensus. The GM guide of 68% implies DRAM/HBM ASP expansion continues even as volumes surge, which is the unusual dynamic of supply-constrained AI memory. This is not a normal semiconductor cycle.
Bullish divergence — all indicators accelerating together:
| Indicator | Q3 FY25 | Q4 FY25 | Q1 FY26 | Trend |
|---|---|---|---|---|
| HBM capacity sold | CY25 sold out | CY26 partial | CY26 100% locked | Accelerating — supply constraint extends timeline |
| DRAM ASP | +sequential | +mid-teens | +20% | Acceleration |
| NAND ASP | +sequential | n/a | +mid-teens | Stable positive |
| Data center revenue % | ~40% | ~50% | ~54% ($7.7B) | Secular shift, mix positive |
| Cloud Memory BU | n/a | n/a | $5.3B (39% of rev) | New ATH |
| Operating cash flow | — | — | $8.4B | Highest ever |
| FCF | $1.9B | $3.0B | $3.9B | +105% in two quarters |
| Inventory days | ~140+ | ~130 | 126 days | Declining (normalization) |
| CapEx guidance | ~$14B | ~$18B | $20B FY26 | Raised — conviction in demand durability |
No divergence visible. Revenue, pricing, FCF, and forward guidance are all pointing in the same direction. The only watch item: inventory at 126 days is still elevated versus the ~90-day normalized range, signaling some caution on NAND/commodity DRAM even as HBM demand far outstrips supply.
Q2 FY26 guide math: $18.7B / $13.6B = +37% QoQ. At 68% GM, gross profit would be $12.7B vs Q1's $7.6B — a $5.1B QoQ gross profit expansion in a single quarter. If accurate, FCF could approach $6–7B for Q2. That would put annualized FCF at $25–28B against a $108B market cap, yielding 23–26% FCF yield.
From stages/scuttlebutt/MU/2026-02-23.md:
Customer: Crucial brand exit — Micron is exiting the Crucial consumer DRAM/SSD brand by February 2026. Deliberate strategic pivot away from commoditized consumer memory toward HBM, data center DRAM, and enterprise NAND. Rational capital allocation — low-margin consumer business deprioritized during supply-constrained HBM cycle. (Source: scuttlebutt stage)
HBM market share dynamics — SK Hynix holds 62% HBM share, Micron 21%, Samsung 17%. Micron overtook Samsung in Q3 2025. Samsung remains unqualified at major hyperscalers (NVIDIA, AMD) for HBM3E in volume production — Micron benefiting directly. (Source: scuttlebutt stage)
Employee sentiment — Glassdoor 3.9/5, Blind 3.4/5. Management quality cited as the primary pain point in employee reviews. CEO Sanjay Mehrotra scores higher externally (credibility, execution track record on HBM ramp) than internally. Moderate flag but not alarming at current growth rates. (Source: scuttlebutt stage)
$200B US investment commitment — Micron announced $200B in US manufacturing investment across Idaho (Fab 1, construction pulled in), New York (Clay fab), and other sites. Idaho Fab 1 first wafers expected mid-CY2027 — capex commitment de-risks domestic supply chain narrative and qualifies Micron for CHIPS Act subsidies. (Source: scuttlebutt stage)
Mobile NAND exit / China headcount reduction — 300+ staff cuts in mobile NAND operations in China as Micron reduces exposure to low-margin NAND and navigates China trade tensions. Strategic alignment with HBM/DC reorientation. (Source: scuttlebutt stage)
HBM4 technology positioning — HBM4 at 11+ Gbps (industry-leading specification). HBM3E already 30% lower power than SK Hynix equivalent — meaningful for hyperscalers where cooling costs matter. Differentiating on power efficiency, not just bandwidth. (Source: transcript / scuttlebutt stage)
Analyst consensus — Zacks consensus: +278% EPS growth FY26. ~26 of 28 covering analysts rated Buy/Strong Buy post-Q1 FY26 earnings. Unusual analyst unanimity. (Source: scuttlebutt stage)
Hiring — Massive US expansion (Idaho, New York manufacturing). Contrasts with China mobile headcount reductions. Hiring pattern consistent with strategic messaging. (Source: scuttlebutt stage)
| Metric | Current | 1Y Ago | Assessment |
|---|---|---|---|
| Market cap | ~$108B | ~$100B | Roughly flat despite earnings tripling |
| P/S TTM | ~2.6x | ~3.5x | Compression — market pricing in cycle peak |
| P/S Fwd (Q2 ann.) | ~1.5x | — | Extraordinarily cheap if $18.7B guide delivers |
| P/E trailing | ~5.2x (on Q1 record) | n/a (loss) | Historical low; price has barely moved vs earnings |
| P/E fwd (Q2 ann.) | ~2.8x | — | The market is pricing in a 70–80% earnings reversal |
| FCF yield TTM | ~14% | — | High single-digit to mid-teens; rising fast |
| FCF yield fwd (Q2 ann.) | ~23–26% | — | If Q2 sustains; implies market prices in sharp reversal H2 FY26 |
Peer comparison: SK Hynix trades at ~6–8x forward P/E. Samsung at ~15x (blended). NVDA at 35–40x forward P/E (the demand driver). Micron trades at a deep discount to both its direct peers and the AI stack it enables. The discount reflects its commodity-cyclical history. The question is whether HBM changes the underlying characterization.
What the market is saying: At $108B market cap and a $33.68 annualized EPS run rate (at Q2 guide), the market is implying FY27/FY28 earnings will revert significantly toward the $3–5B range (implying a 10–15x forward P/E at trough). This is the embedded bear case. If HBM LTAs hold pricing through FY27, the stock is dramatically mispriced.
Micron is not a platform company. It is a commodity-to-specialized memory manufacturer transitioning its mix toward specialized, high-margin memory (HBM) for AI infrastructure.
Secular tailwind: AI compute = GPU memory bandwidth bottleneck. HBM is the only solution at scale. TAM: $35B (CY25) → $100B (CY28) — 40% CAGR, pulled forward 2 years vs. prior estimates. Micron's 21% share of a $100B market = 21BHBMrevenuebyCY28vs. 6B estimated FY26. The flow-through at 65%+ GM would be transformative.
The structural argument: Prior memory cycles were characterized by interchangeable supply (any DRAM is a DRAM). HBM breaks this. It requires dedicated technology (TSV stacking, thermal management, power efficiency), 2-3 year manufacturing lead times, and hyperscaler qualification. Supply cannot respond quickly to price signals. LTAs further lock pricing/volume multi-quarter out. This is why Mehrotra says "50–67% of demand currently unmet" while simultaneously calling CY26 sold out — there is structural shortage, not cyclical shortage.
Counterargument: Commodity DRAM and NAND remain 40–50% of revenue. These do cycle. A consumer/enterprise PC refresh that disappoints (possible given macro) pressures non-HBM pricing. Samsung remains a latent supply threat — they are incentivized to regain HBM share and have enormous capacity. If Samsung's HBM3E qualifies at NVIDIA in CY26, HBM pricing would come under pressure. Mehrotra's "50–67% demand unmet" claim has not been independently verified.
Cyclical mean-reversion — Memory has reverted every prior cycle. If hyperscaler GPU buildout plateaus in CY26-27 (due to ROI concerns on AI capex), HBM demand softens and LTA prices come under renegotiation pressure. Commodity DRAM/NAND could correct simultaneously.
Samsung HBM qualification — Samsung is actively working to qualify HBM3E at NVIDIA and other hyperscalers. If successful, HBM supply increases materially without corresponding demand growth, compressing pricing. Timeline uncertain — could be H2 CY26 or CY27.
Customer concentration — Four hyperscalers drive the majority of HBM revenue. If one reduces AI capex plans (any of Microsoft, Google, Amazon, Meta), Micron feels it disproportionately. No disclosed customer represents >10% of revenue (public disclosure), but hyperscaler concentration in HBM is real.
CapEx execution and stranded assets — FY26 CapEx raised to $20B. $200B committed to US fabs over decade. If demand deteriorates before Idaho Fab 1 (mid-CY2027) comes online, CapEx outspends FCF and balance sheet deteriorates. Prior cycle: Micron's debt peaked at $13.7B (now $11.8B declining).
Tariff / geopolitical risk — China trade tensions (300+ job cuts in mobile NAND already). Any escalation impacting China sales or supply chain disrupts ~10% of revenue. CHIPS Act subsidies are a partial offset but politically contingent.
Q2 FY26 earnings (March 2026) — The $18.7B / 68% GM test. Delivery validates HBM LTA thesis and forces market re-rating. A beat is the single highest-probability near-term catalyst. Guidance beat pattern: +7% Q3 FY25, +27% Q4 FY25, +9% Q1 FY26 — three consecutive beats.
LTA disclosures — Mehrotra called CY26 HBM agreements "much stronger" in structure vs prior but deferred specifics. Formal LTA announcements with volume/price commitments from hyperscalers would provide multi-year revenue visibility and force SOTP revaluation.
HBM4 volume ramp (H2 CY26) — HBM4 at 11+ Gbps, higher ASPs than HBM3E. Qualification at major hyperscalers for next-generation AI accelerators. Successful ramp extends the technology lead vs Samsung and sustains GM expansion.
Samsung disqualification confirmation — If Samsung fails to qualify HBM3E at NVIDIA into CY26, HBM supply remains a two-player (SK Hynix + Micron) market through CY27. Ongoing Samsung struggles at qualification = Micron pricing power sustained.
Idaho Fab 1 pull-forward — First wafers now expected mid-CY2027 (pulled in from prior estimates). US domestic production qualifies for CHIPS Act subsidies and addresses hyperscaler supply-chain resilience requirements. Formal subsidy award announcement would be a catalyst.
Conviction: 4/5. Position: Not disclosed.